|
Abstract:
|
Anti endomysial and anti transglutaminase (EMA/TTG) antibodies
measurements in large population groups, show that celiac disease is significantly more common than
previously thought and 0.5-1% of the population suffer this condition. The recognition of atypical
clinical presentations by active screening of high risk groups is a successful global initiative. In Chile
there is little awareness of the enormous changes occurred in this field. Available national information
on typical presentation of the disease shows that it is found in 1:1836 live births, figure that is
comparable to European societies. Two urgent tasks are required in our country. First, to asses the
Chilean population using EMA and/or TTG. Second, to improve the legal aspects that regulate
consumer information about gluten content in processed foods. We here review the most relevant
aspects to be considered to improve the management of celiac patients and the tasks that require the
participation of health authorities for their implementation. |